SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLXN - has aquired the worldwide exclusive rights ThyroTest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Greenvision10/4/2008 10:08:17 AM
   of 6
 
The test seems successfully been to be.

It concerns is a Chlamydien test (a venereal disease) that on the advance and make can untreated impotent.

Because the releases is now apparently through, the demand would be allowed to climb in the near future and would be allowed to inspire therefore also the share.

I did now 3 Mio shares into the depot and invest for that 500 Euronen.

No large action is, but the share can lie remain also first once.

A course of 0.1 $ in 3 Mio shares, would be think possible is a gigantic profit and I that it.

No purchase recommendation should be now, but it is an attempt value.

CLXN - Strong Buy $$$$

Much good fortune @ all
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext